Guy P Nohra's Net Worth

$205 Million

Estimate Recalculated Jul 10, 2024 03:14PM EST

Who is Guy P Nohra?

Guy P Nohra has an estimated net worth of $205 Million. This is based on reported shares across multiple companies, which include IMMUNE DESIGN CORP., COTHERIX INC, ANESIVA, INC., ZS Pharma, Inc., Allakos Inc., SUTRO BIOPHARMA INC, Esperion Therapeutics, Inc., TREVENA INC, APPLIED GENETIC TECHNOLOGIES CORP, aTYR PHARMA INC, Neothetics, Inc., RENOVIS INC, ATS MEDICAL INC, CUTERA INC, DYNAVAX TECHNOLOGIES CORP, NeurogesX Inc, RIGEL PHARMACEUTICALS INC, ACELRX PHARMACEUTICALS INC, XCYTE THERAPIES INC, ICAGEN INC, FLAMEL TECHNOLOGIES SA, INTARCIA THERAPEUTICS, INC, TorreyPines Therapeutics, Inc., CRUCELL NV, OCCAM NETWORKS INC/DE, AERIE PHARMACEUTICALS INC, ELLIE MAE INC, Bioventus Inc., and Carbylan Therapeutics, Inc..

SEC CIK

Guy P Nohra's CIK is 0001198330

Past Insider Trading and Trends

2014 was Guy P Nohra's most active year for acquiring shares with 29 total transactions. Guy P Nohra's most active month to acquire stocks was the month of January. 2004 was Guy P Nohra's most active year for disposing of shares, totalling 84 transactions. Guy P Nohra's most active month to dispose stocks was the month of March. 2007 saw Guy P Nohra paying a total of $16,415,000.00 for 13,498,673 shares, this is the most they've acquired in one year. In 2003 Guy P Nohra cashed out on 3,325,000 shares for a total of $63,177,849.99, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

IMMUNE DESIGN CORP. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
2.48M
$12.00
—
2.48M
Jul 29
Form 3
—
0
—
—
0
No matching records found

COTHERIX INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-2.95M
$13.50
-$39,876,111.00
0
Jan 9
Form 4
-15.54%
-357.56K
—
—
1.94M
Nov 7
Form 4
-14.96%
-166.94K
$13.00
-$2,170,181.00
948.95K
Oct 14
Form 4
-18.14%
-247.31K
$13.00
-$3,215,082.00
1.12M
Oct 12
Form 4
+169.64%
3.64M
$6.00
$2,499,996.00
5.79M
Oct 15
Form 3
—
0
—
—
0
No matching records found

ANESIVA, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-6.04%
-404.65K
$0.09
-$37,146.87
6.29M
Jan 6
Form 3
—
0
—
—
0
Form 4
∞
2.1M
—
—
2.1M
Feb 18
Form 3
—
0
—
—
0
No matching records found

ZS Pharma, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-1.00K
$90.00
-$90,000.00
0
Dec 17
Form 4
—
0
—
—
0
Jun 18
Form 4
-6.22%
-175.43K
$57.86
-$10,149,794.76
2.65M
Jun 5 - Jun 8
Form 4
-3.80%
-111.60K
$57.30
-$6,394,775.58
2.82M
Jun 3 - Jun 4
Form 4
-9.18%
-296.42K
$58.00
-$17,192,294.53
2.93M
May 29 - Jun 2
Form 4
—
0
—
—
0
Aug 22
Form 4
∞
3.23M
$18.00
—
3.23M
Jun 23
Form 4
∞
3.23M
$18.00
—
3.23M
Jun 23
Form 3
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

Allakos Inc. (ALLK) Snapshot price: $1.27

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-25.77K
$111.64
-$2,876,741.72
0
Mar 4
Form 4
-100.00%
-7.69K
$75.62
-$581,693.10
0
Jun 17
Form 4
-8.32%
-958.55K
—
—
10.56M
Jan 22
Form 4
∞
11.52M
$18.00
—
11.52M
Jul 23
Form 3
—
0
—
—
0
No matching records found